<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Algorithm for growth hormone therapy in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Algorithm for growth hormone therapy in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Algorithm for growth hormone therapy in children</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes the author's approach to adjusting rhGH dosing for patients with GH deficiency. The optimal protocol for IGF-1-based rhGH dosing has not been established, and various protocols are used. Guidelines from the Pediatric Endocrine Society suggest dose adjustment for patients with high IGF-1 levels but do not specify the other dose adjustments outlined above for GH deficiency, because data are lacking on adult height outcomes after IGF-1-based dosing<sup>[1]</sup>.</div><div class="graphic_footnotes"><p>GH: growth hormone;
IGF-1: insulin-like growth factor 1;
SD: standard deviation;
rhGH: recombinant human growth hormone.</p>
<p>* For most patients, we use standard rhGH (somatropin), using a starting dose of approximately 35 micrograms/kg/day (for a total weekly dose of 0.24 mg/kg). For patients with severe GH deficiency, we use a lower starting dose of approximately 20 micrograms/kg/day because these individuals are more sensitive to the drug. For dosing of one of the long-acting rhGH formulations (lonapegsomatropin, somapacitan, or somatrogon), refer to local product information or UpToDate content.</p>
<p>¶ If rhGH is administered daily, then random sampling is sufficient for determining IGF-1 concentration. If a long-acting rhGH preparation is used, interpretation of the IGF-1 result depends on the timing of the sample compared with the preceding dose and the particular long-acting preparation because pharmacokinetics vary among these preparations; refer to UpToDate content. </p>
<p>Δ For monitoring rhGH therapy, target range for IGF-1 is the upper one-half of the normal range (ie, IGF-1 0 to +2 SD). IGF-1 levels below this target range are associated with subnormal growth response to therapy; IGF-1 levels above this target range (ie, &gt;+2 SD) may be associated with possible adverse effects of rhGH. For the long-acting preparations, optimal IGF-1 targets have not been established, but it is reasonable to target mean IGF-1 values in the upper one-half of the normal range, similar to the strategy for standard rhGH preparations.</p>
<p>◊ If the rhGH dose is increased to &gt;0.3 mg/kg/week but IGF-1 levels remain low (&lt;–1 SD) despite good adherence to therapy, the patient may have GH insensitivity. If such patients also fail to have an appropriate growth response to rhGH therapy, the possibility of a GH insensitivity syndrome should be explored; refer to UpToDate content on GH insensitivity.</p>
<p>§ The growth response is typically considered adequate if the height velocity increases to above the 75<sup>th</sup> percentile for the child's age and gender during the period of "catch-up" growth. Refer to UpToDate topic text for details.</p>
¥ In patients with a comorbid disease that contributes to or causes the short stature, IGF-1 levels vary depending on the nutritional status but are typically below the normal range or in the low end of the normal range.</div><div class="graphic_reference">Reference:
<ol>
<li>Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr 2016; 86:361.</li>
</ol></div><div id="graphicVersion">Graphic 113216 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
